Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

INDACO project: COPD and link between comorbidities, lung function and inhalation therapy.

Fumagalli G, Fabiani F, Forte S, Napolitano M, Balzano G, Bonini M, De Simone G, Fuschillo S, Pentassuglia A, Pasqua F, Alimonti P, Carlone S, Sanguinetti CM.

Multidiscip Respir Med. 2015 Jan 27;10(1):4. doi: 10.1186/2049-6958-10-4. eCollection 2015.

2.

Health and social impacts of COPD and the problem of under-diagnosis.

Carlone S, Balbi B, Bezzi M, Brunori M, Calabro S, Foschino Barbaro MP, Micheletto C, Privitera S, Torchio R, Schino P, Vianello A.

Multidiscip Respir Med. 2014 Dec 6;9(1):63. doi: 10.1186/2049-6958-9-63. eCollection 2014. Review.

3.

Clinical efficacy and tolerability of an immune-stimulant(*) constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study.

Carlone S, Minenna M, Morlino P, Mosca L, Pasqua F, Pela R, Schino P, Tubaldi A, Tupputi E, De Benedetto F; Buccalin Trial Group.

Multidiscip Respir Med. 2014 Nov 19;9(1):58. doi: 10.1186/2049-6958-9-58. eCollection 2014.

4.

Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.

Agabiti N, Porretta MA, Bauleo L, Coppola A, Sergiacomi G, Fusco A, Cavalli F, Zappa MC, Vignarola R, Carlone S, Facchini G, Mariotta S, Palange P, Valente S, Pasciuto G, Pezzuto G, Orlandi A, Fusco D, Davoli M, Saltini C, Puxeddu E.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):191-7.

PMID:
25363218
5.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

6.

INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.

Fumagalli G, Fabiani F, Forte S, Napolitano M, Marinelli P, Palange P, Pentassuglia A, Carlone S, Sanguinetti CM.

Multidiscip Respir Med. 2013 Apr 3;8(1):28. doi: 10.1186/2049-6958-8-28.

7.

Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell.

Benelli R, Stigliani S, Minghelli S, Carlone S, Ferrari N.

Prostate. 2013 Jun;73(9):941-51. doi: 10.1002/pros.22640. Epub 2013 Jan 17.

PMID:
23334998
8.

Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR.

Benelli R, Venè R, Minghelli S, Carlone S, Gatteschi B, Ferrari N.

Cancer Lett. 2013 Jan 1;328(1):73-82. doi: 10.1016/j.canlet.2012.09.008. Epub 2012 Sep 23.

PMID:
23010081
9.

The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration.

Benelli R, Venè R, Ciarlo M, Carlone S, Barbieri O, Ferrari N.

Biochem Pharmacol. 2012 Jun 15;83(12):1634-42. doi: 10.1016/j.bcp.2012.03.006. Epub 2012 Mar 17.

PMID:
22445931
10.

Rhino-Bronchial Syndrome. The SIO-AIMAR (Italian Society of Otorhinolaryngology, Head Neck Surgery-Interdisciplinary Scientific Association for the Study of the Respiratory Diseases) survey.

Passali D, Benedetto de F, Benedetto de M, Chiaravalloti F, Damiani V, Passali FM, Bellussi LM; Working Group.

Acta Otorhinolaryngol Ital. 2011 Feb;31(1):27-34.

11.

Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model.

Mirabella T, Cilli M, Carlone S, Cancedda R, Gentili C.

Biomaterials. 2011 May;32(15):3689-99. doi: 10.1016/j.biomaterials.2011.01.071. Epub 2011 Mar 2. Erratum in: Biomaterials. 2012 Jul;33(20):5175. Teodelinda, Mirabella [corrected to Mirabella, Teodelinda]; Michele, Cilli [corrected to Cilli, Michele]; Sebastiano, Carlone [corrected to Carlone, Sebastiano]; Ranieri, Cancedda [corrected to Cancedda, Ranieri]; Chiara, Gentili [corrected to Gentili, Chiara].

PMID:
21371750
12.

Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN.

Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M.

J Hepatol. 2009 Jun;50(6):1132-41. doi: 10.1016/j.jhep.2009.01.027. Epub 2009 Apr 1.

PMID:
19398230
13.

Pulmonary masses in a patient with blue-gray cutaneous hyperpigmentation.

Facchini G, Forte S, Podda P, Piro F, Carlone S.

Eur Rev Med Pharmacol Sci. 2008 Mar-Apr;12(2):113-6.

PMID:
18575161
14.

Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumors.

Paleari L, Trombino S, Falugi C, Gallus L, Carlone S, Angelini C, Sepcic K, Turk T, Faimali M, Noonan DM, Albini A.

Int J Oncol. 2006 Dec;29(6):1381-8.

PMID:
17088975
15.

Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.

Bisacchi D, Noonan DM, Carlone S, Albini A, Pfeffer U.

Biol Chem. 2002 Sep;383(9):1315-20. Review.

PMID:
12437123
16.

HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells.

Cantaluppi V, Biancone L, Boccellino M, Doublier S, Benelli R, Carlone S, Albini A, Camussi G.

AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):965-76.

PMID:
11461682
17.

N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease.

Straface E, Matarrese P, Gambardella L, Forte S, Carlone S, Libianchi E, Schmid G, Malorni W.

Biochem Biophys Res Commun. 2000 Dec 20;279(2):552-6.

PMID:
11118324
18.

Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.

Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A.

Biochem Biophys Res Commun. 2000 Jun 24;273(1):267-71.

PMID:
10873597
19.

Ventilatory and metabolic adaptations to walking and cycling in patients with COPD.

Palange P, Forte S, Onorati P, Manfredi F, Serra P, Carlone S.

J Appl Physiol (1985). 2000 May;88(5):1715-20.

20.

Pulmonary gas exchange and exercise capacity in patients with systemic lupus erythematosus.

Forte S, Carlone S, Vaccaro F, Onorati P, Manfredi F, Serra P, Palange P.

J Rheumatol. 1999 Dec;26(12):2591-4.

PMID:
10606367

Supplemental Content

Loading ...
Support Center